½ÃÀ庸°í¼­
»óÇ°ÄÚµå
1490104

¼¼°èÀÇ ¾Ë·¹¸£±â Ä¡·á ½ÃÀå : À¯Çüº°, Ä¡·áº°, À¯Åë ä³Îº°, Áö¿ªº°

Allergy Treatment Market, By Type, By Treatment, By Distribution Channel, By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Coherent Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    


¡á Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¡Ø º» »óÇ°Àº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è ¾Ë·¹¸£±â Ä¡·á ½ÃÀå ±Ô¸ð´Â 2024³â 211¾ï 9,000¸¸ ´Þ·¯¿¡¼­ 2031³â±îÁö 344¾ï 2,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2024-2031³â »çÀÌ ¿¬Æò±Õ 7.2% ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

º¸°í¼­ ¹üÀ§ º¸°í¼­ »ó¼¼
±âÁØ ¿¬µµ 2023³â 2024³â ½ÃÀå ±Ô¸ð 211¾ï 9,000¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2019-2023³â ¿¹Ãø ±â°£ 2024-2031³â
¿¹Ãø ±â°£ 2024-2031³â CAGR 7.20% 2031³â °¡Ä¡ ¿¹Ãø 344¾ï 2,000¸¸ ´Þ·¯
±×¸². ¾Ë·¹¸£±â Ä¡·á ½ÃÀå Á¡À¯À²(%), Áö¿ªº°, 2024³â
Allergy Treatment Market-IMG1

¼¼°è ¾Ë·¹¸£±â Ä¡·á ½ÃÀåÀº Àü ¼¼°è ¾Ë·¹¸£±â ÁúȯÀÇ À¯º´·ü Áõ°¡·Î ÀÎÇØ Áö³­ ¸î ³â µ¿¾È Å« ¼ºÀå¼¼¸¦ º¸ÀÌ°í ÀÖ½À´Ï´Ù. ¾Ë·¹¸£±â ÁúȯÀº ¸ÕÁö, ²É°¡·ç, °õÆÎÀÌ¿Í °°Àº ȯ°æ ¾Ë·¹¸£°Õ¿¡ ´ëÇÑ ¸é¿ª ü°èÀÇ °ú¹Î ¹ÝÀÀÀ¸·Î ÀÎÇØ ¹ß»ýÇÕ´Ï´Ù. ÃÖ±Ù ÃßÁ¤¿¡ µû¸£¸é Àü ¼¼°è 10¾ï ¸í ÀÌ»óÀÌ ¾Ë·¹¸£±â ºñ¿°À» ¾Î°í ÀÖ´Â °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù. ¶ÇÇÑ, ¿À¿° ¼öÁØÀÇ Áõ°¡¿Í »ýÈ° ½À°üÀÇ º¯È­·Î ÀÎÇØ ¾Ë·¹¸£±â ¹ßº´ÀÇ À§ÇèÀº ´õ¿í Áõ°¡ÇÏ°í ÀÖ½À´Ï´Ù. ÀÌ¿¡ µû¶ó Ç×È÷½ºÅ¸¹ÎÁ¦, ÃæÇ÷ ¿ÏÈ­Á¦, ÄÚ¸£Æ¼ÄÚ½ºÅ×·ÎÀ̵å, ¾Ë·¹¸£°Õ ¸é¿ª¿ä¹ý µî ´Ù¾çÇÑ ¾Ë·¹¸£±â Áõ»óÀ» °ü¸®ÇÒ ¼ö ÀÖ´Â È¿°úÀûÀÎ Ä¡·á ¿É¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ°í ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ:

¼¼°è ¾Ë·¹¸£±â Ä¡·á ½ÃÀåÀº ¿À¿° ¼öÁØ Áõ°¡, ±âÈÄ º¯È­, ½ÅÈï±¹ÀÇ ÀÇ·áºñ ÁöÃâ Áõ°¡ µîÀÇ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ±×·¯³ª Áö¹æ¿¡¼­´Â ¾Ë·¹¸£±â Ä¡·á¿¡ ´ëÇÑ ÀνÄÀÌ ³·°í ¸é¿ªÄ¡·á¿¡ ´ëÇÑ ³ôÀº ºñ¿ëÀÌ ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇÏ°í ÀÖ½À´Ï´Ù. È¿´ÉÀÌ °³¼±µÈ »õ·Î¿î Ä¡·áÁ¦ÀÇ °³¹ßÀº ½ÃÀå¿¡ À¯¸®ÇÑ ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ÁÖ¿ä ±â¾÷µéÀº ¾à¹° ³»¼º ¹®Á¦¸¦ ÇØ°áÇϱâ À§ÇØ °í±Þ Ä¡·á ¿ä¹ýÀ» °³¹ßÇϱâ À§ÇÑ ¿¬±¸°³¹ß¿¡ ÁýÁßÇÏ°í ÀÖ½À´Ï´Ù. ±×·¯³ª »õ·Î¿î ¾Ë·¹¸£±â Ä¡·áÀÇ ½ÂÀο¡ ´ëÇÑ ¾ö°ÝÇÑ ±ÔÁ¦°¡ ¹®Á¦Á¡À¸·Î ÁöÀûµÇ°í ÀÖ½À´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Ư¡

  • ÀÌ º¸°í¼­´Â 2023³âÀ» ±âÁØ ¿¬µµ·Î ÇÏ¿© ¿¹Ãø ±â°£(2024-2031³â)ÀÇ ½ÃÀå ±Ô¸ð¿Í ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» ÅëÇØ ¼¼°è ¾Ë·¹¸£±â Ä¡·á ½ÃÀåÀ» »ó¼¼È÷ ºÐ¼®ÇÕ´Ï´Ù.
  • ¶ÇÇÑ ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀû ¼öÀÍ ¼ºÀå ±âȸ¸¦ ¹àÈ÷°í, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.
  • ¶ÇÇÑ ½ÃÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÌ Ã¤ÅÃÇÑ °æÀï Àü·« µî¿¡ ´ëÇÑ Áß¿äÇÑ ÀλçÀÌÆ®µµ Á¦°øÇÕ´Ï´Ù.
  • ¼¼°è ¾Ë·¹¸£±â Ä¡·á ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷ °³¿äÀ» ±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, ½ÇÀû, Àü·« µîÀÇ ¸Å°³ º¯¼ö¸¦ ±âÁØÀ¸·Î Á¤¸®Çß½À´Ï´Ù.
  • ÁÖ¿ä ±â¾÷À¸·Î´Â Sanofi, Novartis, GSK plc, Johnson & Johnson Services, Inc., F. Hoffmann-La Roche Ltd., Stallergenes Greer, Dermapharm Holding SE, Nicox, Allergy Therapeutics, AbbVie Inc., Teva Pharmaceutical Industries Ltd., Alembic Pharmaceuticals Limited, ALK-Abello A/S, Bausch Health Companies Inc., GLENMARK PHARMACEUTICALS LTD., Perrigo Company plc, Dr Reddy's Laboratories Ltd µîÀÌ ÀÖ½À´Ï´Ù.
  • ÀÌ º¸°í¼­ÀÇ ÀλçÀÌÆ®¸¦ ÅëÇØ ¸¶ÄÉÆà ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯ÇüÈ­, ½ÃÀå È®´ë ¹× ¸¶ÄÉÆà Àü·«¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.
  • ¼¼°è ¾Ë·¹¸£±â Ä¡·á ½ÃÀåÀº ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô ÁøÀÔÀÚ, À繫 ºÐ¼®°¡ µî ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.
  • ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è ¾Ë·¹¸£±â Ä¡·á ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ½±°Ô ³»¸± ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¸ñÀû°ú °¡Á¤

  • Á¶»ç ¸ñÀû
  • °¡Á¤
  • ¾à¾î

Á¦2Àå ½ÃÀå Àü¸Á

  • º¸°í¼­ ¼³¸í
    • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
  • ÁÖ¿ä ¿ä¾à
  • Coherent Opportunity Map(COM)

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
  • ¿µÇ⠺м®
  • ½ÃÀå µ¿Çâ
  • ÁÖ¿ä ¹ßÀü
  • ¿ªÇÐ
  • ±ÔÁ¦ ½Ã³ª¸®¿À
  • Á¦Á¶¾÷ü ¸ÅÃâ
  • Àμö¿Í Á¦ÈÞ ½Ã³ª¸®¿À
  • Á¦Ç° ¹ß¸Å/½ÂÀÎ
  • ÀÚ±Ý Á¶´Þ°ú ÅõÀÚ
  • PEST ºÐ¼®
  • Porters ºÐ¼®

Á¦4Àå ¼¼°èÀÇ ¾Ë·¹¸£±â Ä¡·á ½ÃÀå : COVID-19 ÆÒµ¥¹ÍÀÇ ¿µÇâ

  • ÀüüÀûÀÎ ¿µÇâ
  • Á¤ºÎ À̴ϼÅƼºê
  • COVID-19ÀÇ ½ÃÀå¿¡ ´ëÇÑ ¿µÇâ

Á¦5Àå ¼¼°èÀÇ ¾Ë·¹¸£±â Ä¡·á ½ÃÀå : À¯Çüº°(2019-2031³â)

  • ´« ¾Ë·¹¸£±â
  • õ½Ä
  • ºñ¿°
  • ÇǺΠ¾Ë·¹¸£±â
  • ½ÄÇ° ¾Ë·¹¸£±â
  • ±âŸ

Á¦6Àå ¼¼°èÀÇ ¾Ë·¹¸£±â Ä¡·á ½ÃÀå : Ä¡·áº°(2019-2031³â)

  • Ç׾˷¹¸£±âÁ¦
  • ¸é¿ª¿ä¹ý

Á¦7Àå ¼¼°èÀÇ ¾Ë·¹¸£±â Ä¡·á ½ÃÀå : À¯Åë ä³Îº°(2019-2031³â)

  • ¿ø³» ¾à±¹
  • ¼Ò¸Å ¾à±¹
  • ¿Â¶óÀÎ ¾à±¹

Á¦8Àå ¼¼°èÀÇ ¾Ë·¹¸£±â Ä¡·á ½ÃÀå : Áö¿ªº°(2019-2031³â)

Á¦9Àå °æÀï »óȲ

  • ±â¾÷ °³¿ä
    • Sanofi
    • Novartis
    • GSK plc
    • Johnson & Johnson Services, Inc.
    • F. Hoffmann-La Roche Ltd.
    • Stallergenes Greer
    • Dermapharm Holding SE
    • Nicox
    • Allergy Therapeutics
    • AbbVie Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Alembic Pharmaceuticals Limited
    • ALK-Abello A/S
    • Bausch Health Companies Inc.
    • GLENMARK PHARMACEUTICALS LTD.
    • Perrigo Company plc
    • Dr Reddy's Laboratories Ltd.

Á¦10Àå ¾Ö³Î¸®½ºÆ®ÀÇ °ßÇØ

  • Wheel of Fortune
  • ¾Ö³Î¸®½ºÆ®ÀÇ °ßÇØ
  • Coherent Opportunity Map(COM)

Á¦11Àå Âü°í¹®Çå°ú Á¶»ç ¹æ¹ý

  • Âü°í¹®Çå
  • Á¶»ç ¹æ¹ý
ksm 24.06.12

The global allergy treatment market is estimated to be valued at USD 21.19 Bn in 2024 and is expected to reach USD 34.42 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 7.2% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2024: US$ 21.19 Bn
Historical Data for: 2019 To 2023 Forecast Period: 2024 To 2031
Forecast Period 2024 to 2031 CAGR: 7.20% 2031 Value Projection: US$ 34.42 Bn
Figure. Allergy Treatment Market Share (%), By Region, 2024
Allergy Treatment Market - IMG1

The global allergy treatment market has been witnessing significant growth over the past few years owing to the rising prevalence of allergic disorders worldwide. Allergic disorders are caused when the immune system overreacts to environmental allergens such as dust, pollen, mold, etc. According to recent estimates, over 1 billion people globally suffer from allergic rhinitis. Additionally, the rising levels of pollution and changed lifestyle habits have further increased the risk of developing allergies. As a result, there has been a growing demand for effective treatment options such as antihistamines, decongestants, corticosteroids, and allergen immunotherapy for managing the symptoms of various allergic conditions.

Market Dynamics:

The global allergy treatment market is driven by factors such as increasing pollution levels, changing climate conditions, and rising healthcare expenditure in developing nations. However, the lack of awareness about allergy treatment in rural areas and high costs associated with immunotherapy restrain the market growth. The development of novel therapeutic drugs with improved efficacy offers lucrative opportunities in the market. Key players are focusing on R&D to develop advanced treatment regimens for tackling drug resistance issues. However, stringent regulations for approval of new allergy drugs pose a challenge

Key Features of the Study:

  • This report provides an in-depth analysis of the global allergy treatment market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global allergy treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this includes Sanofi, Novartis, GSK plc, Johnson & Johnson Services, Inc., F. Hoffmann-La Roche Ltd., Stallergenes Greer, Dermapharm Holding SE, Nicox, Allergy Therapeutics, AbbVie Inc., Teva Pharmaceutical Industries Ltd., Alembic Pharmaceuticals Limited, ALK-Abello A/S, Bausch Health Companies Inc., GLENMARK PHARMACEUTICALS LTD., Perrigo Company plc, and Dr Reddy's Laboratories Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • Global allergy treatment market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global allergy treatment market.

Detailed Segmentation-

  • By Type:
    • Eye Allergy
    • Asthma
    • Rhinitis
    • Skin Allergy
    • Food Allergies
    • Others
  • By Treatment:
    • Anti-allergy Drugs
    • Immunotherapy
  • By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Sanofi
    • Novartis
    • GSK plc
    • Johnson & Johnson Services, Inc.
    • Hoffmann-La Roche Ltd.
    • Stallergenes Greer
    • Dermapharm Holding SE
    • Nicox
    • Allergy Therapeutics
    • AbbVie Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Alembic Pharmaceuticals Limited
    • ALK-Abello A/S
    • Bausch Health Companies Inc.
    • GLENMARK PHARMACEUTICALS LTD.
    • Perrigo Company plc
    • Dr Reddy's Laboratories Ltd.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Type
    • Market Snapshot, By Treatment
    • Market Snapshot, By Distribution Channel
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Epidemiology
  • Regulatory Scenario
  • Manufacturer Revenue
  • Acquisitions and Partnerships Scenario
  • Product Launches/Approvals
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Allergy Treatment Market- Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Allergy Treatment Market, By Type, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Eye Allergy
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Asthma
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Rhinitis
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Skin Allergy
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Food Allergies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Allergy Treatment Market, By Treatment, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Anti-allergy Drugs
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Immunotherapy
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Allergy Treatment Market, By Distribution Channel, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Hospital Pharmacies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Retail Pharmacies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Online Pharmacies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Allergy Treatment Market, By Region, 2019 - 2031, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Region, 2019-2031
    • Regional Trends
      • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.S.
      • Canada
      • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
      • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
      • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
      • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • GCC
      • Israel
      • Rest of Middle East
      • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Company Profiles
    • Sanofi
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Novartis
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • GSK plc
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Johnson & Johnson Services, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • F. Hoffmann-La Roche Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Stallergenes Greer
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Dermapharm Holding SE
    • Nicox
    • Allergy Therapeutics
    • AbbVie Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Alembic Pharmaceuticals Limited
    • ALK-Abello A/S
    • Bausch Health Companies Inc.
    • GLENMARK PHARMACEUTICALS LTD.
    • Perrigo Company plc
    • Dr Reddy's Laboratories Ltd.

10. Analyst View

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óÇ°À» ¼±Åà Áß
»óÇ° ºñ±³Çϱâ
Àüü»èÁ¦